Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury

Cytokine

Volumn 69, Issue 2, 2014, Pages 255-262

  Chen, Yi ^a,b   Rothnie, Christine ^c   Spring, Denise ^c   Verrier, Edward ^c   Venardos, Kylie ^d   Kaye, David ^d   Phillips, David J ^b,e   Hedger, Mark P ^b   Smith, Julian A ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e Epworth Research Institute   (Australia)

Author keywords

Activin; Follistatin; Heart; Ischaemia reperfusion

Indexed keywords

ACTIVIN A; FOLLISTATIN; LACTATE DEHYDROGENASE; MESSENGER RNA; OXYGEN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; ACTIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL HYPOXIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART CELL CULTURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; REOXYGENATION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; METABOLISM; PATHOLOGY;

MURINAE; MUS;

ACTIVINS; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; FOLLISTATIN; GENE EXPRESSION REGULATION; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

EID: 84924238154     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.06.017     Document Type: Article

References (34)

1. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010, 10:826-837.
2. Arumugam T.V., Okun E., Tang S.C., Thundyil J., Taylor S.M., Woodruff T.M. Toll-like receptors in ischemia-reperfusion injury. Shock 2009, 32:4-16.
3. Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 2009, 296:H1-12.
4. Cha J., Wang Z., Ao L., Zou N., Dinarello C.A., Banerjee A., et al. Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 2008, 85:1678-1685.
5. Tavener S.A., Kubes P. Cellular and molecular mechanisms underlying LPS-associated myocyte impairment. Am J Physiol Heart Circ Physiol 2006, 290:H800-6.
6. Chong A.J., Shimamoto A., Hampton C.R., Takayama H., Spring D.J., Rothnie C.L., et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004, 128:170-179.
7. Shimamoto A., Chong A.J., Yada M., Shomura S., Takayama H., Fleisig A.J., et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006, 114:I270-4.
8. Phillips D.J., de Kretser D.M., Hedger M.P. Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev 2009, 20:153-164.
9. Hedger M.P., Winnall W.R., Phillips D.J., de Kretser D.M. The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm 2011, 85:255-297.
10. Jones K.L., de Kretser D.M., Clarke I.J., Scheerlinck J.P.Y., Phillips D.J. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. J Endocrinol 2004, 182:69-80.
11. Jones K.L., Mansell A., Patella S., Scott B.J., Hedger M.P., de Kretser D.M., et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA 2007, 104:16239-16244.
12. Miyoshi T., Hirohata S., Uesugi T., Hirota M., Ohnishi H., Nogami K., et al. Relationship between activin A level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention. Clin Chim Acta 2009, 401:3-7.
13. Yndestad A., Ueland T., Oie E., Florholmen G., Halvorsen B., Attramadal H., et al. Elevated levels of activin A in heart failure - potential role in myocardial remodeling. Circulation 2004, 109:1379-1385.
14. Oshima Y., Ouchi N., Shimano M., Pimentel D.R., Papanicolaou K.N., Panse K.D., et al. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury. Circulation 2009, 120:1606-1615.
15. Blount A.L., Vaughan J.M., Vale W.W., Bilezikjian L.M. A Smad-binding element in intron 1 participates in activin-dependent regulation of the follistatin gene. J Biol Chem 2008, 283:7016-7026.
16. Hashimoto O., Nakamura T., Shoji H., Shimasaki S., Hayashi Y., Sugino H. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J Biol Chem 1997, 272:13835-13842.
17. Maeshima A., Zhang Y.Q., Nojima Y., Naruse T., Kojima I. Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats. J Am Soc Nephrol 2001, 12:1685-1695.
18. Kanamoto M., Shimada M., Morine Y., Yoshizumi T., Imura S., Ikegami T., et al. Beneficial effects of follistatin in hepatic ischemia-reperfusion injuries in rats. Dig Dis Sci 2011, 56:1075-1081.
19. Robertson D.M., Klein R., de Vos F.L., McLachlan R.I., Wettenhall R.E., Hearn M.T., et al. The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 1987, 149:744-749.
20. Knight P.G., Muttukrishna S., Groome N.P. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 1996, 148:267-279.
21. Klein R., Robertson D.M., Shukovski L., Findlay J.K., de Kretser D.M. The radioimmunoassay of follicle-stimulating hormone (FSH)-suppressing protein (FSP): stimulation of bovine granulosa cell FSP secretion by FSH. Endocrinology 1991, 128:1048-1056.
22. Winnall W.R., Okuma Y., Saito K., Muir J.A., Hedger M.P. Regulation of interleukin 1alpha, activin and inhibin by lipopolysaccharide in Sertoli cells from prepubertal rats. Mol Cell Endocrinol 2009, 307:169-175.
23. Venardos K.M., Zatta A.J., Marshall T., Ritchie R., Kaye D.M. Reduced l-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury. J Cell Biochem 2009, 108:156-168.
24. Mukerji S.S., Katsman E.A., Wilber C., Haner N.A., Selman W.R., Hall A.K. Activin is a neuronal survival factor that is rapidly increased after transient cerebral ischemia and hypoxia in mice. J Cereb Blood Flow Metab 2007, 27:1161-1172.
25. Zhang L.J., Huang H., Pan P.X., Liu X.J., Wu W.C., Fu H. [Study on the expression of activin-A in myocardial ischemia postconditioning]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009, 40:97-99.
26. Jones K.L., De Kretser D.M., Phillips D.J. Effect of heparin administration to sheep on the release profiles of circulating activin A and follistatin. J Endocrinol 2004, 181:307-314.
27. Chen Y., Phillips D.J., McMillan J., Bedford P., Goldstein J., Wu H., et al. Pattern of activin A and follistatin release in a sheep model of cardiopulmonary bypass. Cytokine 2011, 54:154-160.
28. Wu H., Chen Y., Winnall W.R., Phillips D.J., Hedger M.P. Acute regulation of activin A and its binding protein follistatin in serum and tissues following lipopolysaccharide treatment of adult male mice. Am J Physiol Regul Integr Comp Physiol 2012.
29. Chen Y.G., Lui H.M., Lin S.L., Lee J.M., Ying S.Y. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 2002, 227:75-87.
30. Bartholin L., Maguer-Satta V., Hayette S., Martel S., Gadoux M., Corbo L., et al. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 2002, 21:2227-2235.
31. Aoki F., Kurabayashi M., Hasegawa Y., Kojima I. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 2005, 172:713-720.
32. Patella S., Phillips D.J., Tchongue J., de Kretser D.M., Sievert W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 2006, 290:G137-44.
33. Halestrap A.P., Clarke S.J., Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 2004, 61:372-385.
34. Pachori A.S., Custer L., Hansen D., Clapp S., Kemppa E., Klingensmith J. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway. J Mol Cell Cardiol 2010, 48:1255-1265.